Our findings suggest that everolimus is a promising precision therapy for NPRL2- and NPRL3-related epilepsy, with the potential to reduce seizure frequency, thereby improving patient quality of life.
doi.org/10.1111/epi....

#epilepsy #Epilepsia #ILAE #everolimus #GATOR1complex #mTORpathway